GIGLI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 3.898
EU - Europa 2.991
AS - Asia 2.473
SA - Sud America 332
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.786
Nazione #
US - Stati Uniti d'America 3.831
SG - Singapore 976
IT - Italia 765
PL - Polonia 739
CN - Cina 577
DE - Germania 319
VN - Vietnam 270
BR - Brasile 253
HK - Hong Kong 211
SE - Svezia 189
FR - Francia 161
NL - Olanda 161
FI - Finlandia 144
GB - Regno Unito 136
KR - Corea 129
RU - Federazione Russa 79
IN - India 67
TR - Turchia 51
IE - Irlanda 47
UA - Ucraina 45
BG - Bulgaria 43
MA - Marocco 34
CA - Canada 33
AR - Argentina 32
BD - Bangladesh 32
CH - Svizzera 30
JP - Giappone 28
ES - Italia 26
MX - Messico 22
AT - Austria 21
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 17
IQ - Iraq 16
RO - Romania 16
PK - Pakistan 13
CO - Colombia 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
SA - Arabia Saudita 10
GR - Grecia 9
RS - Serbia 9
EC - Ecuador 8
KE - Kenya 8
LV - Lettonia 8
IL - Israele 7
TW - Taiwan 7
VE - Venezuela 7
JO - Giordania 6
EG - Egitto 5
KG - Kirghizistan 5
PH - Filippine 5
BO - Bolivia 4
DK - Danimarca 4
EU - Europa 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AU - Australia 3
AZ - Azerbaigian 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KZ - Kazakistan 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
GE - Georgia 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
UG - Uganda 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KI - Kiribati 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
Totale 9.779
Città #
Warsaw 679
Singapore 608
Ashburn 527
Fairfield 309
Chandler 290
San Jose 230
Hong Kong 201
Woodbridge 175
Dallas 169
Beijing 153
Trieste 153
Houston 144
Munich 138
Ann Arbor 137
Seattle 135
Cambridge 127
Seoul 122
Hefei 109
Wilmington 104
Chicago 101
Helsinki 95
Los Angeles 83
Ho Chi Minh City 76
Boardman 75
Milan 70
London 69
Council Bluffs 67
Princeton 58
Lauterbourg 57
Hanoi 54
Jacksonville 51
Amsterdam 44
Dublin 42
Rome 42
Sofia 42
Zgierz 42
Santa Clara 41
Columbus 38
Frankfurt am Main 35
New York 34
Moscow 32
Izmir 30
Casablanca 26
Bremen 24
Grafing 24
São Paulo 24
Dearborn 23
Buffalo 21
Orem 21
Phoenix 21
Bern 20
Da Nang 20
Palermo 20
Tokyo 20
Venice 20
Nuremberg 19
Denver 18
Lappeenranta 18
Redondo Beach 18
Düsseldorf 17
Brussels 16
The Dalles 16
Chennai 14
Dong Ket 14
Jinan 14
Salt Lake City 14
Vienna 14
Turku 13
Bologna 12
Brooklyn 12
Guangzhou 12
Montreal 12
Udine 12
Des Moines 11
Elk Grove Village 11
Redwood City 11
Turin 11
Atlanta 10
Mestre 10
Poplar 10
San Diego 10
Belgrade 9
Boydton 9
Dhaka 9
Falls Church 9
Haiphong 9
Nanjing 9
Pune 9
Wroclaw 9
City of London 8
Johannesburg 8
Kunming 8
Naples 8
Redmond 8
Reggio Emilia 8
Riga 8
Rio de Janeiro 8
Toronto 8
Utrecht 8
Washington 8
Totale 6.581
Nome #
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 497
Natural History of Dilated Cardiomyopathy in Children 429
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 388
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 337
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 317
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 309
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 286
Chapter 13: Current Management and Treatment 266
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 261
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 255
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 254
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 247
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 246
Genetics of Dilated Cardiomyopathy: Clinical Implications 244
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 232
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 225
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 217
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 211
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 207
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 203
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 201
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 200
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 196
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 189
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 181
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 176
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 159
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 158
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 157
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 155
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 153
Prognostic role of exercise intensity in familial Filamin C truncating variants 153
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 151
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 149
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 147
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 140
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 138
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 132
The Arrhythmic Phenotype in Cardiomyopathy 130
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 130
null 121
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 121
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 118
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 112
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 110
Heart failure with reduced ejection fraction and monogenic dilated cardiomyopathy: distinct diseases? Insights from randomized controlled trials 106
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 92
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 87
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 79
The heart of dystrophinopathies 64
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 58
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 47
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 44
Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves 33
What Should a Clinical Cardiologist Know About Cardiogenetics? 31
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 26
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 12
Totale 10.087
Categoria #
all - tutte 26.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021162 0 0 0 0 0 0 0 0 0 81 29 52
2021/2022508 22 23 25 21 32 53 24 18 55 41 53 141
2022/2023825 67 116 95 120 68 117 7 77 79 11 48 20
2023/2024595 41 33 27 32 55 77 98 87 16 18 76 35
2024/20251.682 21 57 103 107 132 139 144 130 234 244 174 197
2025/20264.029 400 273 510 449 360 343 582 187 437 488 0 0
Totale 10.087